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Disclaimer of Medical and Legal Advice: The following toolkit is provided for information 
only. The information does not represent legal or medical advice. Additionally, this toolkit 
is not an endorsement for the use of eDOT in the treatment of latent TB infection or TB 
disease. Further studies are required to evaluate the effectiveness of eDOT.
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I. Background
Background
Directly observed therapy (DOT) is the most effective strategy for ensuring that tuberculosis (TB) 
patients adhere to treatment . DOT means that a health care worker or another designated person 
watches the TB patient swallow each dose of the prescribed drugs . However, because DOT can 
be time and resource intensive, some TB programs have expressed an interest in alternative, cost-
efficient methods of delivering DOT for both TB disease and latent TB infection (LTBI) . Electronic 
DOT (eDOT) is an alternative method to in-person DOT in which a patient is remotely observed 
(e .g ., over a smartphone) taking his or her TB medication . 
Purpose
The purpose of this toolkit is to assist TB programs in developing and implementing a TB eDOT 
program . There are a wide variety of eDOT programs throughout the United States . These eDOT 
programs have been designed to meet their respective TB program’s patient needs, utilize available 
resources, and meet management and regulation concerns . Because eDOT programs can be very 
diverse to accommodate individual TB program needs, this toolkit will provide general information 
that can be tailored to fit your program needs . 
Acknowledgements
The following health departments were instrumental in aiding staff in developing this toolkit . The 
health departments shared their eDOT knowledge and documents, reviewed draft materials, and 
provided feedback on what they thought would be helpful to others in starting an eDOT program:
  Boulder County Public Health, Colorado 
  Clark County Public Health, Washington
  Kentucky Tuberculosis Prevention and Control Program
  New York City Department of Health and Mental Hygiene 
  New Jersey Department of Health
  Public Health Seattle-King County, Washington
  Snohomish Health District, Washington
  Tacoma-Pierce County Health Department, Washington
  Washington State Department of Health
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II. Introduction 
What is eDOT? 
eDOT is the use of electronic technologies to remotely monitor TB patients ingesting their 
medication, either in real-time or recorded . In addition to eDOT, this type of DOT is sometimes 
referred to as virtually observed therapy (VOT), mobile DOT (mDOT), remote DOT, video DOT 
(VDOT), and video-enhanced therapy (VET) . 
What Technologies Can be Used to Administer eDOT?
There are multiple technologies available to administer eDOT . Some patients will use their own 
personal device, as long the technology is compatible with the health department’s technology and 
patient security and privacy are not compromised . 
Depending on the resources of the program, the following are some examples of the types of 
communication devices that can be used:
  Smartphone
  Tablet
  Computer with webcam
With each of these devices, there are a multitude of different software programs that can be 
used to provide eDOT (please refer to Appendix A for a list of technologies) . Additionally, eDOT 
encounters can either be live or recorded . During a live eDOT visit, the health care worker and 
the patient schedule a specific day and time to meet virtually, and the health care worker watches 
the patient take his or her medication in real-time . This allows for the health care worker to ask 
the patient how he or she is feeling, check the medications before they are taken, ask the patient 
if he or she is experiencing any side effects, and answer any questions the patient may have . It 
also allows for the health care worker to continue to build rapport with the patient . In contrast, 
recorded eDOT is when the health care worker and the patient do not set a specific time to meet, 
and the patient records himself or herself taking the medications . The patient then saves the 
recording and sends it to the health department for review . This option may be useful when patient 
schedules do not align with the health department, and the health care worker is unable to watch 
the patient live . 
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Is eDOT Right for Your Program and Your TB Patients?
There are many considerations when deciding to develop and implement an eDOT program . It 
should first and foremost be used only when it has been determined that patients’ health will not 
be at risk . 
Benefits of eDOT
The benefits to having an eDOT program include convenience for patients and staff, in addition to 
reduced staff travel cost and time . It is important to note that eDOT is not a complete replacement 
for in-person DOT . In other words, it doesn’t have to be an all or nothing approach; it may work 
for some patients, but not all, and it may work for some part of treatment, but not all. Additionally, 
it is likely that a patient will behave the same whether on eDOT or receiving in-person DOT . If the 
patient has issues around reliability, honesty, substance abuse, or any other behavior that might 
interfere with adherence, these behaviors may not change just because he or she switches from an 
in-person DOT to an eDOT program .  
Challenges of eDOT
Monitoring adverse reactions to TB medications is a major concern when using eDOT . Patients at 
risk for adverse effects should have clinical evaluations at least monthly to identify possible adverse 
reactions to medications, assess adherence, and determine treatment efficacy . Patients should be 
instructed to look for symptoms associated with the most common and most serious reactions to 
the medications they are taking .
Other challenges to using eDOT could be the lost opportunity of building rapport with the patient 
through in-person visits . Some patients thrive on personal contact and may not be motivated to 
remain adherent to treatment by eDOT . Building a personal connection with the patient to support 
treatment completion is vital regardless of the mode of delivering DOT .
Security and Patient Privacy
Security and the protection of a patient’s privacy are of paramount importance when using 
eDOT . There are legal, ethical, and moral issues at stake when patients transmit private health 
data, either in real-time or recorded . For information about the legal permissibility of eDOT, TB 
programs may want to refer to The Network for Public Health Law, which conducted an analysis 
of the legal permissibility of eDOT in several states: www .networkforphl .org/the_network_
blog/2015/01/21/538/video_directly_observed_therapy_for_tuberculosis_legal_and_practical_issues .
The Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule provides national 
standards for protecting the privacy of health information . The Privacy Rule regulates how 
organizations and health care workers use and disclose certain individually identifiable health 
information . Health departments should be well aware of HIPAA requirements . Because eDOT is 
a relatively new method of health care delivery, there are aspects of it that may not have been 
considered when HIPAA was passed . Having both an information technology (IT) representative 
and a legal representative on your workgroup (see workgroup information below) is crucial in 
understanding both the state and federal laws that will govern your choice to implement your own 
eDOT program . 
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III.  Preparing for Implementation
To implement an eDOT program, it can be helpful to follow the steps below:
1. Convene an eDOT workgroup 
2. Identify resources and technologies
3. Develop eDOT policies and protocols
4. Train staff 
1. Convene an eDOT Workgroup
One of the first steps to starting an eDOT program is to establish an eDOT workgroup with 
representatives from the health department’s IT, clinical, legal, outreach, and training and 
education staff . Representatives should have decision-making authority to enhance the ability 
of the workgroup to develop and implement the program . Having representatives from all the 
departments involved creates a sense of ownership, provides an opportunity to problem solve, and 
increases the chance for success .
2. Identify Resources and Technologies
While trying to establish an eDOT program, TB programs will need to research available 
technologies that are compatible with their agency’s security needs, as well as allow for the level 
of privacy needed to secure patient information . Thus, TB programs should work with their IT 
departments to identify technologies that can both be used on health department equipment, as 
well as technologies that are HIPAA compliant . 
When researching technologies, the following factors may be useful to consider:
  Is the technology HIPAA compliant?
  What type of communication device is needed (e .g ., can the technology be used on  
a phone, computer, or tablet?)
  How much are the initial costs of the software?
  How much are the annual costs (e .g ., licensing)?
  What are the IT requirements (e .g ., bandwidth, data)?
  How easy is the program to use?
Additionally, health departments will need to determine what type of communication device to use 
with the eDOT program, as well as who will supply the device . For example, health departments 
will need to determine whether patients can use their own devices or whether the health 
department will provide a device to the patient . If the health department provides one, they  
should consider having the patient sign a loan agreement form which explains their responsibilities 
for the general care and security of the device, as well as how the patient may or may not use it 
for their own personal use (sample patient agreement forms are provided in Appendices B and C) . 
In contrast, if the patient is allowed to use his or her own device, the health department may need 
to explain to patients that the health department will not cover excess data charges as a result of 
participation in eDOT, or they may want to provide a small monetary incentive to cover any  
excess charges .
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3. Develop eDOT policies and protocols 
Health departments should develop their own policies and protocols on the use of eDOT with their 
TB patients . The eDOT policy should be written to reflect the health department’s philosophy on 
the use of eDOT . Below is a sample policy statement:
The state will offer electronic directly observed therapy (eDOT) to patients receiving treatment 
for suspected or confirmed TB disease who meet enrollment criteria. eDOT is an alternative 
method of ensuring that patients adhere to treatment. Patients may choose in-person DOT, 
eDOT, or a combination.  Continued participation in the eDOT program will depend on 
adherence and monthly medical follow-up visits.  
Below are some samples of patient criteria used by other health departments .
Examples of inclusion criteria
  Stabilized on treatment for at least  
2 weeks and noninfectious 
  Motivated patient (as determined by  
case manager) 
  Demonstrated adherence to treatment 
  English speaking or ability to 
effectively communicate with the 
health care worker 
  Drug-susceptible disease 
  Converted sputum smear and culture  
to negative 
  No current alcohol or drug use 
  Managing physician accepts the  
eDOT approach 
  Proficiency in using a smartphone  
or other technology
  Able to accurately identify each 
medication
Examples of exclusion criteria
  Infectious patients 
  Adherence issues 
  Language barriers 
  Multidrug-resistance 
  Minors without accompanying adult 
  Immunocompromised 
  Patient experiences adverse reactions 
  Patients at risk for hepatic 
complications while receiving  
anti-TB medications 
  Patients with disabilities that prevent 
full participation in eDOT such as 
hearing or vision disabilities, or 
physically challenged 
Additionally, health departments will need to determine where and when their staff can administer 
eDOT encounters . For example, will staff only provide eDOT during regular business hours while 
at the office, or can staff provide eDOT outside of regular business hours? To make this decision, 
health departments should consider the privacy of patients . During eDOT encounters, staff need to 
be aware of his or her surroundings . For example, during eDOT encounters, other people should 
not be able to hear the patient’s voice coming through the speaker or see the patient’s face on the 
screen . To help maintain privacy, headphones should be worn and encounters should be done in 
a place that allows for privacy . Some locations have set up privacy screens to hide the computer 
monitors from others . 
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4. Train Staff
Staff should be trained on how to use the technology, as well as how to conduct an eDOT 
encounter . 
The following steps outline the general real-time eDOT process: 
  Prior to each eDOT visit, the health care worker should review the patient information (e .g ., 
chart, medications, notes, appointment date and times) .
  Contact the patient at the specified time (See Appendix D for a sample script for a real-time 
eDOT encounter) . 
  Ask the patient if he/she is having any adverse reactions, address any concerns, and advise 
the patient to seek medical care if necessary . 
  Ask the patient to verify his/her medications with a verbal and visual pill count .
  Observe the patient ingest all of the medication .
  Have the patient confirm verbally that he/she has taken all of the medication and by opening 
their mouth for a visual inspection .
  Confirm the next eDOT visit date and time, and any upcoming in-person clinic visits .
  Remind the patient to call the health care worker if they experience any adverse reactions; 
ensure the patient knows who and how to contact regarding adverse reactions .
For recorded eDOT the steps are similar to the steps for real-time eDOT, with a few exceptions . 
The patient records himself or herself and there is no live interaction with the health care worker . 
The patient logs into a secure system approved by the health department, identifies each pill by 
name and number of pills being taken, takes the medication, states when the next recording is 
due, and then sends the recording to the health department . The staff member then views the 
recording to ensure that the appropriate medication was taken . For recorded eDOT, as with other 
forms of eDOT, it is important that patients continue to comply with regularly scheduled in-person 
appointments to assess for any adverse reactions .
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IV. Implementation
Once all the planning, decision making, and trainings have been completed, the program can begin 
enrolling patients in eDOT . 
The health care worker should discuss the option of eDOT with patients who meet the criteria .  
The patients who choose to enroll should sign all necessary paperwork . The next step would be to 
teach the patients how to use the technology (e .g ., how to log into the system, and how to record 
or live stream) . 
Additionally, health care workers should teach patients the best way to conduct an eDOT visit .  
For example: 
  The patient should be in a well-lit space .
  The health care worker must be able to see the patient’s face .
  The patient should have a glass of water nearby to take their pills .
  The patient should show each pill before taking it; state the name of the medication, shape,  
size, color, and the number of pills he/she is taking .
  The health care worker should ask how the patient is feeling to assess adverse reactions,  
and advise the patient to seek care if necessary .
  The health care worker should confirm the day and time for the next eDOT visit .
All eDOT encounters (and attempts) should be documented by the health department .
There may be a need to re-assess the patient’s ability to participate in eDOT if the patient  
becomes non-adherent, experiences adverse reactions, communication equipment is lost, or  
clinical status worsens .
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V. Monitoring and Evaluation
When evaluating an eDOT program, staff should look at: 
  Completion rates 
  Specifically, TB programs can assess the number of patients who 
• Complete treatment
• Are lost to follow-up 
• Refuse further treatment
• Transfer or move
• Experience treatment failure
• Die (with death attributable to TB)
  Adherence to treatment
  Patient satisfaction with eDOT 
  To assess patient satisfaction with eDOT, programs can assess
• Frequency and reasons patients discontinue eDOT
• Patient perceptions of quality of care and overall satisfaction with eDOT and patient-staff 
relationships/rapport, and patients’ confidence in their ability to adhere to treatment
  Cost analysis 
  To assess the cost of eDOT, programs can look at
• Staff time and transportation costs for eDOT versus in-person DOT
• Cost of hardware/equipment
• Cost of software and licenses
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VI. Appendices
Appendix A:  
Technology Options for Electronic Directly Observed Therapy (eDOT)
Appendix B:  
Patient Electronic Directly Observed Therapy (eDOT) Agreement Form
Appendix C:  
Loaner Agreement for Electronic Directly Observed Therapy (eDOT) Device
Appendix D:  
Health Care Provider Script for Electronic Directly Observed Therapy (eDOT) 
Real-Time Encounter
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Appendix A: Technology Options for Electronic Directly 
Observed Therapy (eDOT)
The Centers for Disease Control and Prevention (CDC) has not made any endorsement for the use of 
electronic directly observed therapy (eDOT) and does not endorse any particular product or application 
for use in eDOT . These options are provided for review and consideration at the individual TB program 
level, and should be reviewed with input from local public health staff and local legal counsel . This list is 
not comprehensive; and due to the rapid change in technology, we recommend that programs conduct 
further research to ensure they have the most current options available . In addition, CDC has made no 
assessment on whether these products are compliant with state or federal privacy laws, including HIPAA .
  AiCure: (https://www .aicure .com) 
  Emocha: miDOT (https://www .emocha .com/solutions/midot) 
  FaceTime (https://support .apple .com/en-us/HT204380) 
  Fuze (www .fuze .com) 
  HipaaBridge (http://hipaabridge .com) 
  ooVoo (www .oovoo .com) 
  Skype www .skype .com/en 
  SureAdhere (http://sureadhere .com) 
  Tango (www .tango .me) 
Adapted from the Minnesota Department of Health
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Appendix B: Patient Electronic Directly Observed 
Therapy (eDOT) Agreement Form
Date: ____ / ____ / ____ 
Patient Name:  ___________________________________
Provider Name:  __________________________________
I, _________________________________ , understand that I have been diagnosed with tuberculosis (TB) 
and have been prescribed medication by a physician to treat this disease . If my disease goes untreated, 
there may be serious consequences: 
  My illness may last longer or become more severe 
  I may spread TB to others 
  I may develop and spread drug-resistant TB 
  I may die from TB 
During my treatment, observation will be performed remotely using electronic directly observed therapy 
(eDOT) .  This may be done using a smartphone or a computer . I understand that the equipment provided 
to me (if any) is property of the Health Department . I agree to return all the equipment to the Health 
Department at the end of my treatment or upon request . I agree to allow the Health Department staff 
watch me take my medicines via eDOT at a prearranged time . 
To complete my treatment and protect my family and friends, I will: 
1 . Come to the health department clinic to give sputum specimens when requested . 
2 . Keep all appointments for medical evaluation and x-rays . 
3 . Participate in eDOT at the agreed upon time with the health care worker . If for any reason I am 
unable to keep an appointment, I will notify the health department as soon as possible to set up 
another appointment . 
eDOT Day(s):  _____________________ Time:  _________________________  
I understand that I may switch back to standard in-person DOT at any time during my treatment . 
I have read this agreement and understand the following (initial each box): 
 ❏ My adherence to this treatment regimen is very important . 
 ❏ I am responsible for the three tasks mentioned above . 
 ❏ If I fail to complete these tasks, legal action may be taken to make sure I complete treatment . 
Patient Signature: ___________________________________________  Date: ____ / ____ / ____
Health Department  
Representative Signature:  _____________________________________Date: ____ / ____ / ____
Adapted from the CDC Self-Study Modules on Tuberculosis, Module 6: Managing Tuberculosis Patients and Improving Adherence
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Appendix C: Loaner Agreement for Electronic Directly 
Observed Therapy (eDOT) Device
Patient Name: ______________________________________  Date of Birth: ____ / ____ / ____
Device (Phone/Tablet/Computer) Type: __________________________Device Number:  _______________
Date Device Received: ____ / ____ / ____  Expected Date of Return: ____ / ____ / ____ 
I agree to the statements below: 
  I received this device to use for my electronic directly observed therapy (eDOT) . The device and its 
accessories are property of the health department; I agree to return all equipment to the health 
department by the date specified above .
  If the device or its accessories are lost or damaged, I may be responsible for the cost of repair or 
replacement . 
  I will take all reasonable steps to keep the device and its accessories safe and working . I will:
• Not loan the device to others . 
• Protect the device from extreme temperatures . 
• Use the protective case when carried, and take care to not damage the screen . 
• Never leave the device in an unsecured area or visible in a locked or unlocked vehicle . 
• Not share passwords with unapproved persons . 
  I am responsible for using good judgment about acceptable use of the device, and I am responsible 
for any additional software, apps, or other files loaded onto the device . 
Unacceptable use: Unacceptable uses include, but are not limited to: 
  Engaging in illegal or offensive online activity such as sending or receiving abusive, pornographic, 
sexually explicit, violent, or threatening material . 
  Sending or receiving of material that violates state or federal laws is not allowed . This includes, 
but is not limited to, confidential information, copyrighted material, online piracy, and threatening 
material . 
  Introducing harmful code such as viruses, worms, spyware, malware, and adware . 
Patient / Legal Representative: _________________________________  Date: ____ / ____ / ____
Health Department  
Staff Member Signature:  ______________________________________Date: ____ / ____ / ____
Adapted from Clark County Public Health (Washington State)
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Appendix D: Health Care Provider Script for Electronic 
Directly Observed Therapy (eDOT) Real-Time Encounter
1 . Staff and patient connect at the scheduled time using the agreed upon technology .
2 . “Hello, this is ______________________________ (health care provider) .”
3 . “Can you please confirm that I am speaking to ______________________________ (patient)?”
4 . “Have you had any negative reactions to the TB medicine?” 
If yes, follow your health department’s protocol to ensure the patient receives medical attention .  
If no adverse reactions, then proceed with step #5 .
5 . “Show me each pill separately and say the name of each medication .”
6 . “Put each pill in your mouth and drink at least 4 ounces of fluid after you take your pills .”
7 . “Please open your mouth and show me that the pills were swallowed .”
8 . “Let’s confirm the time and date for the next eDOT appointment (or in-person clinic appointment 
if upcoming) . Your next eDOT appointment is tomorrow at (time) . Your next in-person clinic 
appointment is scheduled for (day) at (time) .”
9 . “Do you have any other concerns?”
10 . “Thank you . I look forward to talking with you tomorrow at (confirmed time of next call) .  
Good-bye .”
Adapted from the New Jersey Department of Health
